Regarding the new ESO guideline on pharmacological interventions for long-term secondary prevention after ischemic stroke or transient ischemic attack: Current evidence does not allow simplified recommendations

Eur Stroke J. 2022 Sep;7(3):339-340. doi: 10.1177/23969873221108745. Epub 2022 Jun 24.

Christian H Nolte^{1

2

3}, Jan F Scheitz^{1

2}, Hebun Erdur¹, Heinrich J Audebert^{1

2}

¹ Klinik für Neurologie mit Experimenteller Neurologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institute of Health (BIH), Berlin, Germany.
² Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
³ German Centre for Cardiovascular Research, Partner Site Berlin, Germany.

No abstract available